Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTYX Ventyx Biosciences, Inc.

盘前交易 12-31 04:45:50 EST

8.75

-0.33

-3.63%

最高9.10	最低8.61	成交量95.58万
今开9.08	昨收9.08	日振幅5.34%
总市值6.24亿	流通市值4.69亿	总股本7,136万
成交额836.79万	换手率1.78%	流通股本5,356万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTYX","market":"US","secType":"STK","nameCN":"Ventyx Biosciences, Inc.","latestPrice":8.75,"timestamp":1767128400000,"preClose":9.08,"halted":0,"volume":955810,"delay":0,"floatShares":53555855,"shares":71358638,"eps":-1.499056,"marketStatus":"盘前交易","change":-0.33,"latestTime":"12-31 04:45:50 EST","open":9.08,"high":9.095,"low":8.61,"amount":8367887.155599999,"amplitude":0.053414,"askPrice":10.09,"askSize":100,"bidPrice":7.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.499056,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767191400000},"marketStatusCode":1,"adr":0,"listingDate":1634788800000,"exchange":"NASDAQ","adjPreClose":8.75,"postHourTrading":{"tag":"盘后","latestPrice":8.75,"preClose":8.75,"latestTime":"17:27 EST","volume":258318,"amount":2260288.1336,"timestamp":1767133657087},"volumeRatio":1.3688583545428517,"impliedVol":0.8206,"impliedVolPercentile":0.3373},"requestUrl":"/m/hq/s/VTYX","defaultTab":"news","newsList":[{"id":"1141554398","title":"Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1141554398","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141554398?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:04","pubTimestamp":1764677057,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1103972831","title":"Ventyx Biosciences 第三季度每股收益为 -0.32 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103972831","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103972831?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571773,"startTime":"0","endTime":"0","summary":"11月6日 - Ventyx Biosciences 第三季度运营费用为 2487.4万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"1198420202","title":"Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1198420202","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198420202?lang=zh_cn&edition=full","pubTime":"2025-11-07 05:03","pubTimestamp":1762462995,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2578521118","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.30%报6.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578521118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578521118?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:33","pubTimestamp":1761312831,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时33分，Ventyx Biosciences, Inc.股票出现异动，股价大幅拉升5.30%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213351a6cc308d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213351a6cc308d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":1},{"id":"1102173291","title":"异动解读 | Ventyx Biosciences股价夜盘大涨5.15%，口服药物试验结果利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1102173291","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102173291?lang=zh_cn&edition=full","pubTime":"2025-10-24 12:52","pubTimestamp":1761281566,"startTime":"0","endTime":"0","summary":"生物科技公司Ventyx Biosciences, Inc.在周五夜盘交易中股价大涨5.15%，引发投资者广泛关注。据报道，Ventyx Biosciences的一款口服药物在临床试验中表现出色，成功降低了心脏病风险指标。此前，Ventyx Biosciences的股票在常规交易时段就已经上涨了92.7%，显示出市场对该公司前景的乐观预期。这一重大突破不仅有望为心脏病患者带来新的治疗选择，也彰显了Ventyx Biosciences在生物制药领域的创新能力。投资者对这一潜在的市场机遇反应积极，推动公司股价在盘后继续攀升。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"1138119942","title":"异动解读 | 万替生物科技股价夜盘大跌8.33%，此前因积极临床试验结果大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1138119942","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138119942?lang=zh_cn&edition=full","pubTime":"2025-10-24 08:02","pubTimestamp":1761264152,"startTime":"0","endTime":"0","summary":"万替生物科技股票在周四夜盘交易中出现大幅下跌，跌幅高达8.33%，引发市场关注。据悉，万替生物科技的股价在当天早些时候曾飙升102.6%，创下近两年来的最高价。这一涨势是由该公司宣布其口服药物VTX3232在临床试验中取得积极结果所推动。然而，尽管早盘表现强劲，万替生物科技的股价在夜盘交易中却出现显著回落。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"2577652535","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.06%报8.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577652535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577652535?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:42","pubTimestamp":1761226940,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时42分，Replimune Group, Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.72美元/股，成交量45.7567万股，换手率0.59%，振幅4.23%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。消息层面，截至21时42分，《Leerink Partners上调Replimune至买入评级，上调目标价至13美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321422094d9d68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321422094d9d68b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VTYX","BK4007","REPL"],"gpt_icon":0},{"id":"2577453148","title":"Savara, Inc.盘中异动 股价大涨5.23%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577453148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577453148?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:34","pubTimestamp":1761226483,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时34分，Savara, Inc.股票出现异动，股价快速上涨5.23%。截至发稿，该股报4.33美元/股，成交量6.7028万股，换手率0.04%，振幅4.86%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Ventyx Biosciences, Inc.、Ibio, Inc.、Moleculin Biotech, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为147.52%、77.55%、62.61%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Tango Therapeutics, Inc.、Ventyx Biosciences, Inc.，振幅分别为22.45%、20.67%、18.13%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213443a470c52f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023213443a470c52f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007","SVRA","BK4139"],"gpt_icon":0},{"id":"2577534910","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大涨5.23%报3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577534910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577534910?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:33","pubTimestamp":1761226408,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时33分，Sonnet Biotherapeutics Holdings, Inc.股票出现波动，股价快速上涨5.23%。截至发稿，该股报3.82美元/股，成交量1.9353万股，换手率0.28%，振幅0.18%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Ventyx Biosciences, Inc.、Ibio, Inc.、Moleculin Biotech, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为147.34%、76.27%、60.96%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Ventyx Biosciences, Inc.、Tango Therapeutics, Inc.，振幅分别为22.45%、18.13%、15.36%。Sonnet Biotherapeutics Holdings, Inc.公司简介：Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321332994d9d2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321332994d9d2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SONN","VTYX"],"gpt_icon":0},{"id":"1141080761","title":"Ventyx Biosciences 股价几乎翻倍，口服心脏疾病药物在中期试验中降低炎症；最新上涨94.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141080761","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141080761?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:33","pubTimestamp":1761226389,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences 股价几乎翻倍，口服心脏疾病药物在中期试验中有效降低炎症；最新上涨94.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"1143626700","title":"Ventyx Biosciences 股份在盘前上涨 69.2% 至 $6.53，因口服心脏病药物在中期试验中减少炎症","url":"https://stock-news.laohu8.com/highlight/detail?id=1143626700","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143626700?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:51","pubTimestamp":1761213073,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences 股份在盘前上涨 69.2% 至 $6.53，因其口服心脏病药物在中期试验中显示出减少炎症的效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1184278084","title":"Ventyx Biosciences公布Vtx3232在肥胖及心血管风险因素参与者中进行的二期研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184278084","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184278084?lang=zh_cn&edition=full","pubTime":"2025-10-23 04:03","pubTimestamp":1761163395,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences公布Vtx3232在肥胖及心血管风险因素参与者中进行的二期研究积极顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2572681567","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572681567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572681567?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:37","pubTimestamp":1759498638,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时37分，Ventyx Biosciences, Inc.股票出现异动，股价大幅拉升6.52%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100321371894b9ce96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100321371894b9ce96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2572373307","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.12%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572373307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572373307?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:21","pubTimestamp":1759242065,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时21分，Ventyx Biosciences, Inc.股票出现异动，股价快速拉升5.12%。截至发稿，该股报3.18美元/股，成交量17.9273万股，换手率0.25%，振幅6.61%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930222105971a7a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930222105971a7a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2566191658","title":"Ventyx Biosciences, Inc.盘中异动 快速跳水5.15%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566191658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566191658?lang=zh_cn&edition=full","pubTime":"2025-09-09 00:07","pubTimestamp":1757347632,"startTime":"0","endTime":"0","summary":"北京时间2025年09月09日00时07分，Ventyx Biosciences, Inc.股票出现异动，股价快速跳水5.15%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909000712a4bbbd88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909000712a4bbbd88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2558660555","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.16%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558660555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558660555?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:45","pubTimestamp":1754941545,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时45分，Ventyx Biosciences, Inc.股票出现波动，股价大幅下挫5.16%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203454597416a75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203454597416a75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2557631578","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅上涨7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557631578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557631578?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:37","pubTimestamp":1754660228,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时37分，Ventyx Biosciences, Inc.股票出现波动，股价急速上涨7.20%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821370994d7cafd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821370994d7cafd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2556383214","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556383214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556383214?lang=zh_cn&edition=full","pubTime":"2025-07-31 23:36","pubTimestamp":1753976190,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日23时36分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升5.03%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为2.59%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731233630a46de2a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731233630a46de2a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2555576150","title":"Ventyx Biosciences, Inc.盘中异动 大幅跳水5.43%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555576150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555576150?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:35","pubTimestamp":1753799720,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时35分，Ventyx Biosciences, Inc.股票出现波动，股价急速下挫5.43%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729223520a469de72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729223520a469de72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2554772235","title":"Ventyx Biosciences, Inc.盘中异动 急速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772235?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:32","pubTimestamp":1753709578,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时32分，Ventyx Biosciences, Inc.股票出现异动，股价快速下挫5.35%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213259a6c61603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213259a6c61603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.ventyxbio.com","stockEarnings":[{"period":"1week","weight":-0.0353},{"period":"1month","weight":-0.125},{"period":"3month","weight":1.4306},{"period":"6month","weight":3.2067},{"period":"1year","weight":2.9238},{"period":"ytd","weight":2.9954}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.0986},{"period":"1year","weight":0.1679},{"period":"ytd","weight":0.1722}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.032083},{"month":2,"riseRate":0.5,"avgChangeRate":0.472556},{"month":3,"riseRate":0.25,"avgChangeRate":-0.139982},{"month":4,"riseRate":0.75,"avgChangeRate":0.007413},{"month":5,"riseRate":0.75,"avgChangeRate":0.169529},{"month":6,"riseRate":0.25,"avgChangeRate":-0.151975},{"month":7,"riseRate":1,"avgChangeRate":0.16945},{"month":8,"riseRate":0.25,"avgChangeRate":0.018158},{"month":9,"riseRate":0.75,"avgChangeRate":0.25535},{"month":10,"riseRate":0.25,"avgChangeRate":0.269009},{"month":11,"riseRate":0.4,"avgChangeRate":-0.114905},{"month":12,"riseRate":0.6,"avgChangeRate":-0.00451}],"exchange":"NASDAQ","name":"Ventyx Biosciences, Inc.","nameEN":"Ventyx Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ventyx Biosciences, Inc.,VTYX,Ventyx Biosciences, Inc.股票,Ventyx Biosciences, Inc.股票老虎,Ventyx Biosciences, Inc.股票老虎国际,Ventyx Biosciences, Inc.行情,Ventyx Biosciences, Inc.股票行情,Ventyx Biosciences, Inc.股价,Ventyx Biosciences, Inc.股市,Ventyx Biosciences, Inc.股票价格,Ventyx Biosciences, Inc.股票交易,Ventyx Biosciences, Inc.股票购买,Ventyx Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}